ORCID

Abstract

The prescribing of psychotropic medications for people with an intellectual disability has changed. In many locations across England, antidepressants have become the most widely prescribed psychotropic. In the context of the current NHS England STOMP programme to reduce inappropriate psychotropic prescribing for people with intellectual disability, there is an urgent need to understand whether this change reflects evidence-based use of the medications involved. There has been little analysis into the benefits or problems associated with the change and whether it is of concern. This paper offers a variety of possible explanations and opportunities to improve clinical practice and policy.

DOI

10.1192/bjp.2022.34

Publication Date

2022-08-22

Publication Title

British Journal of Psychiatry

Volume

221

Issue

2

ISSN

0007-1250

Keywords

Antidepressants, developmental disorders, information technologies, intellectual disability, polypharmacy

First Page

488

Last Page

493

Share

COinS